Protein Expression Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein Expression Market 

5.1. COVID-19 Landscape: Protein Expression Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein Expression Market, By Expression Systems

8.1. Protein Expression Market, by Expression Systems, 2022-2030

8.1.1. Prokaryotic expression systems

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Mammalian cell systems

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Insect cell systems

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Yeast systems

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Other systems

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Protein Expression Market, By Product

9.1. Protein Expression Market, by Product, 2022-2030

9.1.1. Reagents

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Competent cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Expression vectors

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Services

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Instruments

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Protein Expression Market, By Instruments 

10.1. Protein Expression Market, by Instruments, 2022-2030

10.1.1. Therapeutic

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Industrial

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Research

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Protein Expression Market, By End-use 

11.1. Protein Expression Market, by End-use, 2022-2030

11.1.1. Pharmaceutical and biotechnological companies

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Academic research

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Contract research organizations

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Protein Expression Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.1.2. Market Revenue and Forecast, by Product (2017-2030)

12.1.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.1.4. Market Revenue and Forecast, by End-use (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.2.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.2.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.3.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.3.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.4.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.4.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.5.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Expression Systems (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Instruments (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 13. Company Profiles

13.1. Agilent Technologies, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bio-Rad Laboratories, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Merck KGaA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Promega Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. New England Biolabs

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Qiagen

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Takara Bio, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Report Detail

Proceed To Buy

USD 3500
USD 7000